IL17A and arthritic joint disease: Supporting this assumption, it was demonstrated in mice that SFN dampened the clinical severity of experimental arthritis by inhibiting the production of cartilage destructive metalloproteinases and the expression of IL-17 and TNF-α (9, 60).